Table 2.
Patient Demographics, Medical History, and Hospital Interventions
All Patients | Adult Hospital | Pediatric Hospital | |
---|---|---|---|
40 | 17 | 23 | |
Years of age [mean (interquartile range)/median] | 26 (54)/8 | 56 (27)/56 | 3.3 (12)/1.1 |
Female sex (%) | 17 (43) | 6 (35) | 11 (48) |
Definite case (%) | 32 (80) | 14 (82) | 18 (78) |
Past Medical History | |||
Asthma (%) | 5 (13) | 2 (12) | 3 (13) |
COPD (%) | 2 (5) | 2 (12) | 0 |
Other chronic lung diseases (%) | 4 (10) | 0 | 4 (17) |
Past neonatal intensive care unit admission (%) | N/A | Unknown | 12 (57)a |
Immunocompromised (%)a | 11 (28) | 4 (24) | 7 (30) |
Admission Diagnosis | |||
Pneumonia (%) | 3 (7.5) | 3 (18) | 0 |
Other infection (%) | 11 (28) | 6 (35) | 5 (22) |
Noninfectious (%) | 26 (65) | 8 (47) | 18 (78) |
Malignancy/scheduled chemotherapy (%) | 5 (13) | 1 (5.9) | 4 (17) |
Intervention After Onset of Respiratory Viral Infection Symptoms | |||
Transfer to intensive care unit (%) | 5 (13) | 2 (12) | 3 (13) |
Intubation (%) | 6 (15) | 1 (5.8) | 5 (22) |
Started on antibiotics (%) | 17 (43) | 7 (41) | 10 (44) |
Died during same hospitalization (%) | 5 (13) | 2 (12) | 3 (13) |
Abbreviations: COPD, chronic obstructive pulmonary disease; HIV, human immunodeficiency virus; N/A, not applicable.
aSubjects were considered immunocompromised if they had any of the following: positive HIV test, report of HIV infection; receiving a prolonged course of steroids or other immunomodulatory medications; neutropenia during the hospitalization; or undergoing active chemotherapy during the hospitalization.